Articles by Stan Bernard, MD

Jul 1, 2010
By: Stan Bernard, MD

Teva Pharmaceuticals has emerged as the industry's most formidable foe.

3D Competitive Analysis

As the pharma industry transitions to a more challenging product life cycle profile, companies need to employ innovative approaches for assessing competitors, stakeholders, and markets
Apr 1, 2010
By: Stan Bernard, MD

Companies need to employ 3D analysis to assess markets, stakeholders, and competitors

Think Different

Oct 1, 2009
By: Stan Bernard, MD

Game-changers can create competitive advantages for pharmaceutical companies and products.

Forget Brand vs. Brand—This is War

Jul 1, 2009
By: Stan Bernard, MD

Increasingly, pharma companies are expanding from brand vs. brand to battle at the franchise, portfolio, and corporate levels.

When Sharks Attack

Apr 1, 2009
By: Stan Bernard, MD

Launching a product? Your competition likely plans to interfere. Here's how to counter a counter-launch.

Pharma vs. Pharma

Jan 1, 2009
By: Stan Bernard, MD

Every industry has a life cycle, and pharma's has just entered its competitive stage. Here's how to prepare.

Consumerization: Pandora's Pillbox

By going direct-to-consumer, the industry unwittingly unleashed a swarm of opportunities for other players to enter the pharmaceutical fray. And they made the most of it. Now, a decade later, pharma is feeling the fallout in consumer trust and product value. It's time to take back control.
Jun 1, 2007
By: Stan Bernard, MD

To harness consumerization to improve the industry's image and enhance the value of its products, pharma leaders need to focus on the "Four Cs": commitment, choice, collaboration, and customization